Given that chemotherapy as a stand-alone therapeutic strategy may not be sufficient to effectively treat cancer,there is increasing interest in combination of chemotherapy and alternative therapies.Photodynamic therap...Given that chemotherapy as a stand-alone therapeutic strategy may not be sufficient to effectively treat cancer,there is increasing interest in combination of chemotherapy and alternative therapies.Photodynamic therapy has the advantages of high selectivity and low side effects,so the combination of photodynamic therapy and chemotherapy has become one of the most appealing strategies for tumor treatment.In this work,we constructed a nano drug codelivery system(PPDC)to realize the combined treatment of chemotherapy and photodynamic therapy through encapsulating chemotherapeutic drug dihydroartemisinin and photosensitizer chlorin e6 in PEG-PCL.The potentials,particle size and morphology of nanoparticles were characterized by dynamic light scattering and transmission electron microscopy.We also investigated the reactive oxygen species(ROS)generation and drug release ability.The antitumor effect in vitro was investigated by methylthiazolyldiphenyl-tetrazolium bromide assays and cell apoptosis experiments,and the potential cell death mechanisms were explored by ROS detection and Western blot analysis.The in vivo antitumor effect of PPDC was evaluated under the guidance of fluorescence imaging.Our work provides a potential antitumor treatment approach and expands the application of dihydroartemisinin for breast cancer therapy.展开更多
The non-selective cytotoxicity of toxins limits the clinical relevance of the toxins.In recent years,toxins have been widely used as warheads for antibody-drug conjugates(ADCs)due to their eff-cient killing activity a...The non-selective cytotoxicity of toxins limits the clinical relevance of the toxins.In recent years,toxins have been widely used as warheads for antibody-drug conjugates(ADCs)due to their eff-cient killing activity against various cancer cells.Although ADCs confer certain targeting properties to the toxins,low drug loading capacity,possible immunogenicity,and other drawbacks also limit the po-tential application of ADCs.Recently,non-ADC delivery strategies for toxins have been extensively investigated.To further understand the application of toxins in anti-tumor,this paper provided an over-view of prodrugs,nanodrug delivery systems,and biomimetic drug delivery systems.In addition,toxins and their combination strategies with other therapies were discussed.Finally,the prospect and challenge of toxins in cancertreatmentwerealso summarized.展开更多
基金approved by the Ethical Committee of Fujian Medical University(No.FJMU IACUC 2021-0317)conducted by following the guidelines from the Ethics Committee and national regulations of China.
文摘Given that chemotherapy as a stand-alone therapeutic strategy may not be sufficient to effectively treat cancer,there is increasing interest in combination of chemotherapy and alternative therapies.Photodynamic therapy has the advantages of high selectivity and low side effects,so the combination of photodynamic therapy and chemotherapy has become one of the most appealing strategies for tumor treatment.In this work,we constructed a nano drug codelivery system(PPDC)to realize the combined treatment of chemotherapy and photodynamic therapy through encapsulating chemotherapeutic drug dihydroartemisinin and photosensitizer chlorin e6 in PEG-PCL.The potentials,particle size and morphology of nanoparticles were characterized by dynamic light scattering and transmission electron microscopy.We also investigated the reactive oxygen species(ROS)generation and drug release ability.The antitumor effect in vitro was investigated by methylthiazolyldiphenyl-tetrazolium bromide assays and cell apoptosis experiments,and the potential cell death mechanisms were explored by ROS detection and Western blot analysis.The in vivo antitumor effect of PPDC was evaluated under the guidance of fluorescence imaging.Our work provides a potential antitumor treatment approach and expands the application of dihydroartemisinin for breast cancer therapy.
基金This work was supported by the National Postdoctoral Foundation of China(No.2023M730375)Liaoning Province Department of Education Project(No.LJKMZ20221365,China)+3 种基金the State Key Laboratory of Natural and Biomimetic Drugs(No.K202215,China)the National Natural Science Foundation of China(No.82173766)Liaoning Province Applied Basic Research Program(No.2022JH2/101300097,China)the Natural Science Foundation of Shandong Province(No.ZR2021QH084,China)。
文摘The non-selective cytotoxicity of toxins limits the clinical relevance of the toxins.In recent years,toxins have been widely used as warheads for antibody-drug conjugates(ADCs)due to their eff-cient killing activity against various cancer cells.Although ADCs confer certain targeting properties to the toxins,low drug loading capacity,possible immunogenicity,and other drawbacks also limit the po-tential application of ADCs.Recently,non-ADC delivery strategies for toxins have been extensively investigated.To further understand the application of toxins in anti-tumor,this paper provided an over-view of prodrugs,nanodrug delivery systems,and biomimetic drug delivery systems.In addition,toxins and their combination strategies with other therapies were discussed.Finally,the prospect and challenge of toxins in cancertreatmentwerealso summarized.